1. Home
  2. /
  3. Venture Capital
  4. /
  5. Broken String Biosciences Series...

News / Venture Capital

Broken String Biosciences Series A fundraising

18 September 2023
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures (DvH Ventures). As part of the round, Yoann Bonnamour, Mérieux Equity Partners, and Arnaud Autret, Illumina Ventures, join the Company’s Board of Directors.

Download

Press Release
Download

Related News

arrow-up-right
arrow-up-right
arrow-up-right